RxDoctor Payments Data

Michelle Chun

Family · Johns Creek, GANPI 1487121679

Payments from drug & device makers

$4,053in general payments, 2019–2025

Across 233 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amarin Pharma, Inc.$555
  • Gilead$307
  • Lilly USA, LLC$258
  • Novo Nordisk$209
  • Amgen$188
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$4,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,053 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
VoqueznaVonoprazan Fumarate13$10,901
LinzessLinaclotide13$8,082
Albuterol Sulfate HfaAlbuterol Sulfate22$415
Levocetirizine Dihydrochloride60$312
Methylprednisolone57$271
Losartan Potassium24$194
Gabapentin18$151
Azithromycin78$148
Amlodipine Besylate32$103
Omeprazole25$86
Tamsulosin Hcl13$84
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$79
Atorvastatin Calcium23$60
Alendronate Sodium21$59
Metformin Hcl22$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Phathom Pharmaceuticals, Inc.Voquezna$36$10,90113 claims
AbbVieLinzess$1,315$8,08213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Johns Creek

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →